key: cord-0741364-7dc3vz3d authors: Andolfo, Immacolata; Russo, Roberta; Lasorsa, Vito Alessandro; Cantalupo, Sueva; Rosato, Barbara Eleni; Bonfiglio, Ferdinando; Frisso, Giulia; Abete, Pasquale; Cassese, Gian Marco; Servillo, Giuseppe; Esposito, Gabriella; Gentile, Ivan; Piscopo, Carmelo; Villani, Romolo; Fiorentino, Giuseppe; Cerino, Pellegrino; Buonerba, Carlo; Pierri, Biancamaria; Zollo, Massimo; Iolascon, Achille; Capasso, Mario title: Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19 date: 2021-03-17 journal: iScience DOI: 10.1016/j.isci.2021.102322 sha: 850ca586232a488fef8c45724b545d465d02589a doc_id: 741364 cord_uid: 7dc3vz3d The established risk factors of coronavirus disease 2019 (COVID-19) are advanced age, male sex and comorbidities, but they do not fully explain the wide spectrum of disease manifestations. Genetic factors implicated in the host antiviral response provide for novel insights into its pathogenesis. We performed an in-depth genetic analysis of chromosome 21 exploiting the genome-wide association study data, including 6,406 individuals hospitalized for COVID-19 and 902,088 controls with European genetic ancestry from the COVID-19 Host Genetics Initiative. We found that five single nucleotide polymorphisms within TMPRSS2 and near MX1 gene show associations with severe COVID-19. The minor alleles of the five SNPs correlated with a reduced risk of developing severe COVID-19 and high level of MX1 expression in blood. Our findings demonstrate that host genetic factors can influence the different clinical presentations of COVID-19 and that MX1 could be a potential therapeutic target. The recent severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) pandemic has 59 caused so far more than over 2.5 million deaths (https://covid19.who.int/). The coronavirus 60 disease 2019 , caused by the SARS-Cov-2, is associated with diverse clinical 61 presentations, ranging from asymptomatic or mildly symptomatic infections to respiratory Two whole exome sequencing studies showed that inactivating rare mutations in genes 77 belonging to the type I interferon pathway predispose to life-threatening COVID-19 78 pneumonia (van der Made et al., 2020; Zhang et al., 2020). Addionally, preliminary results 79 on a small set of Italian cases suggest that coding variants in TMPRSS2 and PCSK3 may 80 contribute to the variability in infection susceptibility and severity. (Latini et al., 2020) . 81 In our previous opinion article, based on the analysis of allele frequencies across different 82 populations and expression quantitative triat loci (eQTLs) data, we hypothesized that 83 common variants on chromosome 21 near TMPRSS2 and MX1 genes may be genetic risk 84 factors associated with the COVID-19 different clinical manifestations (Russo et al., 2020) . 85 Both TMPRSS2 and MX1 are involved in the host response to SARS-CoV-2 infection. ACE2 86 is the main entry receptor for SARS-CoV-2 (Wang et al., 2020) . Entry depends on the 87 binding of the surface unit S1 of the spike (S) protein of the virus to the receptor. SARS-88 CoV-2 engages ACE2 as the entry receptor and employs the host cellular TMPRSS2 for S-89 J o u r n a l P r e -p r o o f To prove that common variants at TMPRSS2/MX1 (21q22.3) locus may affect the 113 susceptibility to severe COVID-19 onset, we analyzed the summary statistics of a large 114 available GWAS dataset released by the COVID-19 Host Genetics Initiative (COVID-19 115 Host Genetics Initiative, 2020). The dataset includes 6,406 hospitalized cases and 902,088 116 controls with European ancestry (" Table S1 . Study groups that have contributed to GWAS 117 meta-analyses of the COVID-19 Host Genetics Initiative, Related to Figure 1"). A region on 118 chromosome 21 appears to be significantly associated with severe COVID-19 at the genome-119 wide level (https://www.covid19hg.org/results/) as also demonstrated in a recently published 120 GWAS study (Pairo-Castineira et al., 2020). To investigate whether more than one 121 association signals may exist at chromosome 21, we selected 74 SNPs showing a P≤1×10 -5 122 and we identified 3 independent loci among them (" Table S2 . Summary statistics at 123 chromosome 21 from GWAS dataset, Related to Figure 1 ). The most significant signal was 124 represented by rs13050728 (P=2.76×10 -12 , OR=0.83, Figure 1a ) that maps within the 125 INFRA2 gene. The other two signals showed a suggestive significance level (P≤1×10 −5 ) and 126 were tagged by rs111783124 (P=2.39×10 -6 , OR=1.17, Figure 1b ) and rs3787946 127 (P=2.73×10 -6 , OR=0.87, Figure 1c ), respectively. The rs3787946 maps in an intronic region 128 of TMPRSS2 and the first closest gene was MX1 (Figure 1c) ; herein, we named this locus as 129 "TMPRSS2/MX1". An in-depth inspection of the TMPRSS2/MX1 locus showed that 13 SNPs 130 were in linkage disequilibrium (LD) with the lead rs3787946 (r 2 >0.8, Table 1 ) and that the 5 131 most significant SNPs (P-values ranging from 2.7×10 -6 to 5.8×10 -6 , Table 1 We then investigated the predicted functional role of the 14 SNPs by GWAVA and CADD 160 tools. We found that two out of the five most significant SNPs, i.e. rs9983330 and 161 rs12329760, showed the first (combined score=26) and second (combined score=23) most 162 significant score ( Table 1) . The rs12329760 was classified as a coding variant (p.Val197Met) 163 localized in the exon 6 of the TMPRSS2 gene and was predicted to be pathogenic (PolyPhen-164 2=probably damaging and SIFT=deleterious). 165 The most significant disease-associated SNPs are eQTLs for MX1 in blood 167 We verified if the top five SNPs (Table 1) Table S5 . Results of eQTL analysis for the common variants at TMPRSS2/MX1 locus, 175 Related to Figure 2 ). The two SNPs rs12329760 and rs2298660 were confirmed as eQTLs for 176 The data on eQTLs related to TMPRSS2 must be interpreted with caution as these eQTL 282 Ventilation of coronavirus disease 2019 375 patients Baseline Characteristics and Outcomes 378 of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region Dexamethasone in Hospitalized 382 Patients with Covid-19 -Preliminary Report Global analysis of the impact of environmental 385 perturbation on cis-regulation of gene expression What chances 387 do children have against COVID-19? Is the answer hidden within the thymus? A Multibasic Cleavage Site in 389 the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells SARS-CoV-2 Cell Entry 393 Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor New insights into genetic susceptibility of COVID-19: an 397 ACE2 and TMPRSS2 polymorphism analysis The role of the thymus in COVID-19 disease severity: 399 implications for antibody treatment and immunization COVID-19 and Genetic Variants of 402 Protein Involved in the SARS-CoV-2 Entry into the Host Cells Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the 405 transmembrane protease TMPRSS2 Enhanced isolation of SARS-CoV-2 by 408 TMPRSS2-expressing cells Genetic mechanisms 411 of critical illness in Covid-19 First comprehensive 413 computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to 414 SARS-CoV-2 among different populations Presenting 417 Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With 418 COVID-19 in the Genetic 420 Analysis of the Coronavirus SARS-CoV-2 Host Protease TMPRSS2 in Different Populations The 23andMe COVID-19 Team Trans-ethnic analysis reveals genetic and non-genetic associations with COVID-19 425 susceptibility and severity. medRxiv ACE2 and TMPRSS2 427 polymorphisms in various diseases with special reference to its impact on COVID-19 disease Presence of Genetic Variants Among Young Men With Severe COVID-19 Variability in genes 433 related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and 434 CTSL) and its potential use in association studies Genetic variants in TMPRSS2 and Structure of SARS-CoV-2 437 spike glycoprotein and TMPRSS2 complex Initial whole-genome sequencing and analysis of the host genetic contribution 440 to COVID-19 severity and susceptibility Systematic 443 identification of trans eQTLs as putative drivers of known disease associations Myxovirus Resistance Proteins: Potential Biomarkers for Differentiating 447 Viral from Bacterial Infections Inborn errors of type I IFN immunity in patients 450 with life-threatening COVID-19